CEL-SCI Corporation | Finanzwire

BRIEF

published on 09/04/2024 at 12:36, 3 months 17 days ago

First Berlin Equity Research Reiterates Buy Rating for CEL-SCI Corporation

Financial Results FDA Approval Multikine First Berlin Equity CEL-SCI
PRESS RELEASE

published on 09/04/2024 at 12:31, 3 months 17 days ago

Original-Research: CEL-SCI Corporation (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates recommendation on CEL-SCI Corp. Analyst reiterates Buy rating and USD 6.20 target price. Positive results from financials and bias analysis

First Berlin Equity Research BUY Rating CEL-SCI Corporation USD 6.20 Target Price Bias Analysis
BRIEF

published on 06/11/2024 at 10:41, 6 months 10 days ago

First Berlin Equity Research Reaffirms Buy Recommendation for CEL-SCI Corporation

FDA Approval Clinical Study CEL-SCI Corporation Multikine Equity Research
PRESS RELEASE

published on 06/11/2024 at 10:36, 6 months 10 days ago

Original-Research: CEL-SCI Corporation (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating for CEL-SCI Corporation after FDA's positive outcome on Multikine's type B meeting, adjusting price target to USD 6.20

FDA First Berlin Equity Research Stock Market CEL-SCI Corporation Multikine
PRESS RELEASE

published on 02/14/2024 at 15:51, 10 months 6 days ago

Original-Research: CEL-SCI Corporation (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms BUY rating for CEL-SCI Corporation (ISIN: US1508376076) with USD 8.40 price target. Completion of US manufacturing facility for lead drug Multikine expected in H1 2024

First Berlin Equity Research CEL-SCI Corporation Multikine US Manufacturing Facility USD 8.40 Price Target

Published on 12/21/2024 at 01:30, 12 hours 11 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 12 hours 11 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 13 hours 36 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 13 hours 41 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 14 hours 11 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 12 hours 50 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 12 hours 56 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 18 hours 30 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 18 hours 45 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 19 hours 41 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 1 hour 23 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 19 hours 41 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 19 hours 46 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 23 hours 41 minutes ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 19 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News